These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4942003)

  • 21. Special application of fluorescence histochemistry: studies on eight monoamine oxidase inhibitors in brain neurons.
    Bartonícek VJ
    Pharmacology; 1970; 4(1):16-24. PubMed ID: 4393462
    [No Abstract]   [Full Text] [Related]  

  • 22. Monoamine oxidase in man: enzyme characteristics in platelets, plasma, and other human tissues.
    Murphy DL; Donnelly CH
    Adv Biochem Psychopharmacol; 1974; 12(0):71-85. PubMed ID: 4607554
    [No Abstract]   [Full Text] [Related]  

  • 23. Physicochemical properties, development, and regulation of central and peripheral monoamine oxidase activity.
    Youdim MB; Holzbauer M; Woods HF
    Adv Biochem Psychopharmacol; 1974; 12(0):11-28. PubMed ID: 4608303
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of monoamine oxidase inhibitors and some related compounds on lipid metabolism in rat. Plasma free fatty acids and lipoprotein lipase of the heart and adipose tissue.
    Mattila M; Torsti P
    Ann Med Exp Biol Fenn; 1966; 44(3):397-400. PubMed ID: 4382354
    [No Abstract]   [Full Text] [Related]  

  • 25. Interaction of D-cycloserine with the action of some monoamine oxidase inhibitors.
    Vítek V; Rysánek K
    Biochem Pharmacol; 1965 Oct; 14(10):1417-24. PubMed ID: 4379549
    [No Abstract]   [Full Text] [Related]  

  • 26. Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors.
    Aghajanian GK; Graham AW; Sheard MH
    Science; 1970 Sep; 169(3950):1100-2. PubMed ID: 5449322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 28. Selective inhibition of monoamine oxidase in rat brain mitochondria.
    Fuller RW; Warren BJ; Molloy BB
    Biochem Pharmacol; 1970 Nov; 19(11):2934-6. PubMed ID: 5512701
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of thyroid monoamineoxidase by thyroxine and some specific inhibitors.
    Knopp J; Torda T
    Endokrinologie; 1979; 73(3):356-8. PubMed ID: 499103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Turnover rates of monoamine oxidases: recovery of the irreversibly inhibited enzyme activity and the influence of isoproterenol.
    Planz G; Quiring K; Palm D
    Life Sci I; 1972 Feb; 11(3):147-60. PubMed ID: 4653196
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of pretreatment with monoamine oxidase inhibitors or (+)-amphetamine on leptazol convulsions in mice and rats.
    Turner TA; Spencer PS
    J Pharm Pharmacol; 1968 Dec; 20():Suppl:122S+. PubMed ID: 4388144
    [No Abstract]   [Full Text] [Related]  

  • 32. The accumulation of [3H]noradrenaline in the adrenergic nerve fibres of reserpine-treated mice.
    Carlsson A; Waldeck B
    J Pharm Pharmacol; 1967 Mar; 19(3):182-90. PubMed ID: 4382340
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on monoamine oxidase. 5. Enzymic differences in the monoamine oxidases in the brain and liver].
    Tatsuo F
    Nihon Yakurigaku Zasshi; 1968 Jul; 64(4):393-8. PubMed ID: 4387722
    [No Abstract]   [Full Text] [Related]  

  • 34. [Apropos of the mechanism of action of monoamine oxidase-inhibitors on the coronary circulation].
    Mirzoian RS
    Farmakol Toksikol; 1965; 28(1):51-5. PubMed ID: 5845043
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits].
    Kocherga VI; Gotovtseva EP
    Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of perturbation of cerebral amine metabolism on operationally defined learning and memory processes of goldfish.
    Stahl SM; Narotzky RA; Boshes B; Zeller EA
    Biol Psychiatry; 1974 Dec; 9(3):295-323. PubMed ID: 4441577
    [No Abstract]   [Full Text] [Related]  

  • 37. Monoamine oxidase: multiple forms and selective inhibitors.
    Youdim MB; Collins GG; Sandler M
    Biochem J; 1971 Feb; 121(3):34P-36P. PubMed ID: 4399166
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of monoamine oxidase inhibitors on the N-demethylation and hydrolysis of meperidine.
    Eade NR; Renton KW
    Biochem Pharmacol; 1970 Jul; 19(7):2243-50. PubMed ID: 5520372
    [No Abstract]   [Full Text] [Related]  

  • 39. Furoxanobenzofuroxan, a selective monoamine oxidase inhibitor.
    Bolt AG; Sleigh MJ
    Biochem Pharmacol; 1974 Jul; 23(14):1969-77. PubMed ID: 4425396
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.